Delivery Order SPE2DB20D1100-SPE2DB24FZ06L
Award Date 12/1/23
Potential Completion Date 12/4/23
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order valued at approximately $16,508 by the Defense Logistics Agency Troop Support Medical (DLA) to supply 75mg Gemtesa tablets. The order is for 90 tablets to be delivered to a facility in Conshohocken, Pennsylvania by August 29, 2023. No additional details were provided regarding the original solicitation or whether this delivery order is associated with any particular...
- Amerisourcebergen Drug Corp has been awarded a firm fixed price delivery order valued at $6,480.50 by the Defense Logistics Agency (DLA) Troop Support Medical supply chain program. Under the order, the prime contractor will deliver 30 boxes of 75mg Gemtesa tablets to the DLA distribution center located in Conshohocken, Pennsylvania by November 6, 2023. The award is associated with DLA's pharmaceutical and medical supply procurement efforts to support military treatment facilities. No set-aside...
- The Defense Logistics Agency Troop Support Medical awarded a $3,675.47 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 75 mg Gemtesa tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver 30 tablets to a location in Conshohocken, Pennsylvania by July 6, 2023 to fulfill the agency's requirements. As a component of the Department of Defense, the Defense Logistics Agency supports America's armed forces by procuring,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) under a firm fixed-price contract valued at $8,854.17. The order was competitively awarded without set-aside designation and is scheduled for completion by October 21, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its corporate office location. This delivery order represents a transaction...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency (DLA) on December 19, 2025, for the supply of Gemtesa 75 mg tablets (90-count units) with a ceiling value of $64,780.17. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 22, 2025, and represents a continuation of the vendor's extensive pharmaceutical supply relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,279.87 to AmerisourceBergen Drug Corp for Gemtesa 75 mg tablets (30-count package) on August 1, 2025, with an ultimate completion date of August 4, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to federal military and healthcare systems. The place of performance is AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $16,640.77 to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90-count units) on July 11, 2025, with an ultimate completion date of July 14, 2025. This firm fixed-price delivery order was competitively awarded without set-aside provisions and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $17,230.90 to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Gemtesa 75 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 27, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its Corporate Office location...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Gemtesa 75 mg tablets. The $12,956.42 order will be performed at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with a completion date of January 23, 2024. This delivery order is part of AmerisourceBergen's existing contract with DLA to supply pharmaceuticals and medical supplies in support of military...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $36.6K to AmerisourceBergen Drug Corp for the supply of Gemtesa 75 mg tablets (90 count) on December 18, 2025, with completion expected by December 19, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The pharmaceutical products will be delivered to...